Your Medication Information.
- Published in:
- Brown University Psychopharmacology Update, 2022, v. 33, n. 11, p. 9, doi. 10.1002/pu.30945
- Publication type:
- Article
Works matching IS 10685308 AND DT 2022 AND VI 33 AND IP 11
Results: 11
1
2
Balovaptan fails to improve socialization in youths with autism.
- Published in:
- Brown University Psychopharmacology Update, 2022, v. 33, n. 11, p. 8, doi. 10.1002/pu.30944
- Publication type:
- Article
3
Study finds use of psychotropics linked to higher risk of traffic crashes.
- Published in:
- Brown University Psychopharmacology Update, 2022, v. 33, n. 11, p. 8, doi. 10.1002/pu.30943
- Publication type:
- Article
4
Expansion of take‐home methadone has minimal impact on overdose.
- Published in:
- Brown University Psychopharmacology Update, 2022, v. 33, n. 11, p. 6, doi. 10.1002/pu.30942
- Publication type:
- Article
5
Adequate antidepressant treatment lowers risk of harm from co‐prescribed opioids.
- Published in:
- 2022
- Publication type:
- Letter to the Editor
6
Opioids and antidepressants: When is the mantra wrong?
- Published in:
- Brown University Psychopharmacology Update, 2022, v. 33, n. 11, p. 7, doi. 10.1002/pu.30940
- Publication type:
- Article
7
Study finds LAI antipsychotics linked with lower risk of hospitalization.
- Published in:
- Brown University Psychopharmacology Update, 2022, v. 33, n. 11, p. 4, doi. 10.1002/pu.30939
- Publication type:
- Article
8
LAI antipsychotics associated with lower risk of TD than oral versions.
- Published in:
- Brown University Psychopharmacology Update, 2022, v. 33, n. 11, p. 3, doi. 10.1002/pu.30938
- Publication type:
- Article
9
Generic substitution of antidepressants.
- Published in:
- Brown University Psychopharmacology Update, 2022, v. 33, n. 11, p. 2, doi. 10.1002/pu.30937
- Publication type:
- Article
10
Third‐generation antipsychotics associated with impulse control disorders.
- Published in:
- Brown University Psychopharmacology Update, 2022, v. 33, n. 11, p. 1, doi. 10.1002/pu.30936
- Publication type:
- Article
11
Risk of drug‐gene interaction reduced under pharmacogenomic testing.
- Published in:
- Brown University Psychopharmacology Update, 2022, v. 33, n. 11, p. 1, doi. 10.1002/pu.30935
- Publication type:
- Article